Animal models of status epilepticus and temporal lobe epilepsy: a narrative review N Nirwan, P Vyas, D Vohora Reviews in the Neurosciences 29 (7), 757-770, 2018 | 69 | 2018 |
Phosphoinositide-3-kinases as the novel therapeutic targets for the inflammatory diseases: current and future perspectives P Vyas, D Vohora Current drug targets 18 (14), 1622-1640, 2017 | 24 | 2017 |
The role of melatonin and its analogues in epilepsy S Khan, M Khurana, P Vyas, D Vohora Reviews in the Neurosciences 32 (1), 49-67, 2021 | 22 | 2021 |
The role of endocannabinoid pathway in the neuropathology of Alzheimer’s disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the … S Bajaj, S Jain, P Vyas, S Bawa, D Vohora Brain Research Bulletin 174, 305-322, 2021 | 20 | 2021 |
Loss of protection by antiepileptic drugs in lipopolysaccharide-primed pilocarpine-induced status epilepticus is mediated via inflammatory signalling P Vyas, RK Tulsawani, D Vohora Neuroscience 442, 1-16, 2020 | 15 | 2020 |
Amelioration of oxidative stress utilizing nanoemulsion loaded with bromocriptine and glutathione for the management of Parkinson's disease MU Ashhar, P Vyas, D Vohora, PK Sahoo, K Nigam, S Dang, J Ali, ... International Journal of Pharmaceutics 618, 121683, 2022 | 13 | 2022 |
Effect of lacosamide on neuroinflammation-mediated seizures comorbid with depression in C57BL/6 mice–role of kynurenine pathway S Agarwal, P Vyas, N Nirwan, D Vohora Epilepsy & Behavior 123, 108262, 2021 | 6 | 2021 |
Approaches for ear-targeted delivery systems in neurosensory disorders to avoid chronic hearing loss mediated neurological diseases R Verma, P Vyas, J Kaur, MN Javed, M Sarafroz, M Ahmad, SJ Gilani, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2022 | 5 | 2022 |
Pharmaceutical regulations for complementary medicine P Vyas, D Vohora Pharmaceutical Medicine and Translational Clinical Research, 233-264, 2018 | 4 | 2018 |
Dual targeting by inhibition of phosphoinositide-3-Kinase and mammalian target of rapamycin attenuates the neuroinflammatory responses in murine hippocampal cells and seizures … P Vyas, R Tulsawani, D Vohora Frontiers in Immunology 12, 739452, 2021 | 2 | 2021 |
Innovative targets for asthma and COPD: exploring the existing and screening the new!! P Vyas, D Vohora Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2016 | 2 | 2016 |
High Doses of ANA12 Improve Phenobarbital Efficacy in a Model of Neonatal Post-Ischemic Seizures P Vyas, I Chaturvedi, Y Hwang, J Scafidi, SD Kadam, CE Stafstrom International journal of molecular sciences 25 (3), 1447, 2024 | 1 | 2024 |
Methods for the Screening of New Chemical Entities for Deciphering Neuroinflammatory and Associated Pathways in Seizures: An In Vitro Perspective P Vyas, R Tulsawani, D Vohora Experimental and Translational Methods to Screen Drugs Effective Against …, 2021 | 1 | 2021 |
Development of a novel glucose‐dendrimer based therapeutic targeting hyperexcitable neurons in neurological disorders A Sharma, N Sah, R Sharma, P Vyas, W Liyanage, S Kannan, ... Bioengineering & Translational Medicine, e10655, 2024 | | 2024 |
847: PAIN PERCEPTIONS IN NEURODEVELOPMENTAL DISORDERS: EVALUATION IN A MOUSE MODEL OF RETT SYNDROME A Bedner, P Vyas, N Sah, C Zhang, A Uniyal, C Smith-Hicks, Y Guan, ... Critical Care Medicine 52 (1), S396, 2024 | | 2024 |
Overactivated PI3K/Akt/mTOR pathway mediates anti-inflammatory potential of anti-seizure medications in lipopolysaccharide primed pilocarpine-induced HT-22 cells P Vyas, R Tulsawani, D Vohora BRITISH JOURNAL OF PHARMACOLOGY 178 (24), 4964-4965, 2021 | | 2021 |
Dual inhibition of phosphoinositide-3-kinase and mammalian target of rapamycin mitigates lipopolysaccharide-primed Pilocarpine induced seizures in C57BL/6 mice P Vyas, R Tulsawani, D Vohora BRITISH JOURNAL OF PHARMACOLOGY 178 (2), 463-464, 2021 | | 2021 |
Evaluation of phosphoinositide 3 kinase mammalian target of rapamycin and their dual inhibition in experimental epilepsy P Vyas Delhi, 0 | | |